Sitgliptin (Janumet)
Sitgliptin
Msd (Pty) Ltd
Registration
- Applicant
- Msd (Pty) Ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Janumet 50/500 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 500,0 mg SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITGLIPTIN 50,0 mg | 50/500 mg | 42108942/21.2/1089 | Registered | Not determined | None |
| Janumet 50/850 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 850,0 mg SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITGLIPTIN 50,0 mg | 50/850 mg | 42109042/21.2/1090 | Registered | Not determined | None |
| Janumet 50/1000 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 1000,0 mg SITAGLIPTIN PHOSPHATE EQUIVALENT TO SITGLIPTIN 50,0 mg | 50/1000 mg | 42109142/21.2/1091 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.